Avenue Therapeutics, Inc.
ATXI
$0.58
-$0.01-1.70%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.33M | 3.50M | 2.59M | 2.60M | 4.92M |
Total Receivables | 800.00K | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 35.00K | 92.00K | 78.00K | 28.00K | 69.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 4.16M | 3.59M | 2.67M | 2.63M | 4.99M |
|
|||||
Total Current Assets | 4.16M | 3.59M | 2.67M | 2.63M | 4.99M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 4.16M | 3.59M | 2.67M | 2.63M | 4.99M |
|
|||||
Total Accounts Payable | 456.00K | 431.00K | 301.00K | 657.00K | 592.00K |
Total Accrued Expenses | 873.00K | 830.00K | 499.00K | 287.00K | 522.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | 1.00K | 16.00K | 29.00K | 47.00K |
Total Other Current Liabilities | -- | 1.00K | 16.00K | 29.00K | 47.00K |
Total Current Liabilities | 1.33M | 1.26M | 816.00K | 973.00K | 1.16M |
|
|||||
Total Current Liabilities | 1.33M | 1.26M | 816.00K | 973.00K | 1.16M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.33M | 1.26M | 816.00K | 973.00K | 1.16M |
|
|||||
Common Stock & APIC | 108.16M | 107.94M | 105.38M | 103.65M | 102.72M |
Retained Earnings | -104.10M | -104.43M | -102.58M | -101.04M | -97.96M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 4.06M | 3.51M | 2.80M | 2.61M | 4.76M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 4.06M | 3.51M | 2.80M | 2.61M | 4.76M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -1.23M | -1.18M | -941.00K | -958.00K | -937.00K |
Total Equity | 2.83M | 2.33M | 1.86M | 1.65M | 3.83M |
|